Background and Purpose-The new pooled cohort risk (PCR) equations is sex-and race-specific estimates of the 10-year risk of atherosclerotic cardiovascular events among disease-free adults. Little is known about the association between the PCR model and presence of silent brain infarction (SBI 
S ilent brain infarction (SBI)
, which is frequently seen on MRI, is common in older people without a clinical history of stroke. 1 Because SBI is frequently accompanied by white matter hyperintensities 2, 3 and associated with an increased risk of cognitive decline [4] [5] [6] and clinical stroke, 7 timely identification and optimal implementation of strategies to mitigate future stroke and vascular cognitive impairment could be of great use to physicians.
Advanced age and hypertension are the most widely accepted risk factors for SBI. 8 For Framingham risk score, increasing levels of the aggregate stroke risk score and cardiovascular risk score were associated with significantly related to prevalent risk of SBI (odds ratio, 1.27) 9 and cognitive decline, 10 respectively. However, studies on risk score for predicting SBI are few. Framingham 10-year prediction model provides a sex-specific absolute risk of vascular events, but with little validation in multiethnic populations. 11 To raise validation of the risk tool in an external population, the American College of Cardiology and the American Heart Association provided a guideline on the assessment of cardiovascular risk and issued new sex-and race-specific estimates of the 10-year risk for hard atherosclerotic cardiovascular disease (ASCVD) events for black and white men and women in 2013 as the American College of Cardiology/American Heart Association PCR equations. 12 This model has been validated to show a good discrimination of incident ASCVD risk in a population without ASCVD at baseline. 13 In this study, we evaluated the predictive ability and discriminative capacity of the PCR model for MRI-defined SBI among otherwise neurologically healthy individuals.
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Methods

Study Population
Because the PCR equations was originally designed for adults aged 40 to 79 years, 12 we reviewed a consecutive series of 1736 neurologically healthy consecutive subjects aged from 40 to 79 years who visited Seoul National University Hospital Healthcare System for routine health check-ups from January 2006 through December 2011 and who underwent brain MRI. Neurologically healthy subjects were defined as those who had not experienced a stroke or transient ischemic attack and had no neurological symptoms or signs. Of 1736 participants, 133 participants had missing smoking status or lipid component of PCR model and were excluded from the final analysis, yielding a total of 1603 (92.3%) subjects. All subjects provided informed consent, and the study was approved by the institutional review board at Seoul National University Hospital (26-2012-1).
Baseline Data Collection
Clinical information including age, sex, prior diagnosed comorbid conditions, smoking status and use of antihypertensive, antidiabetic and lipid-lowering medications were obtained and a physical examination was performed on each subject by a trained physician. The PCR score was calculated using the coefficients for the equations for calculating the estimate of an individual's 10-year ASCVD risk, 12, 13 which is shown in Table I in the online-only Data Supplement. Because the PCR model is mainly applicable to black and non-Hispanic whites, it is recommended that other ethnic groups use of the equations for non-Hispanic whites. 12 Given that there are no data available concerning the PCR in Asian populations, we also calibrated the study participants as black to compare discrimination capacity between white and black models. Blood pressure was measured 2 times following a standardized protocol and averaged for analysis. All serum samples of participants were obtained in the fasting state for 12 hours. Diabetes mellitus was defined as a fasting glucose level of ≥126 mg/dL or a hemoglobin A1c ≥6.5%, 14 or self-report of a prior diagnosis of diabetes mellitus with current use of insulin or oral hypoglycemic medications.
Definition of SBI
SBI was defined as a round or ovoid ischemic lesion of diameter between 3 and 15 mm in diameter and well-demarcated hyperintensity on T2-weighted image and central hypointensity with surrounding hyperintensity on fluid-attenuated inversion recovery image. 15 To avoid any ambiguous enrollment of participants with SBI, we precluded ill-defined lesions, diffuse white matter changes and hemorrhagic lesions. SBIs were divided into deep subcortical (ds-SBI) and hemispheric SBI (hs-SBI) according to their lesion location because hs-SBI was more related to dementia than ds-SBI. 5 SBIs in the corona radiata, basal ganglia, internal capsule, thalamus, brain stem or cerebellum were categorized as ds-SBIs, and those in the cortical gray matter or white matter adjacent to cortex were categorized as hs-SBIs. 5 hs-SBI was included without limitation of maximum size. Participants having ≥2 SBI lesions were defined as multiple SBIs.
MRI Protocol
MRI examinations were performed at field strengths of 1.5 T (Signa, GE Healthcare, Milwaukee, WI or Magnetom SONATA, Siemens, Munich, Germany). The imaging protocol used consisted of: T2-weighted fast spin-echo (repetition time/echo time=5000/127 ms), T1-weighted spin-echo (repetition time/echo time=500/11 ms), and fluid-attenuated inversion recovery (repetition time/echo time=8800/127 ms; inversion time=2250 ms) imaging. Images were obtained as 26 transaxial slices per scan. The slice thickness was 5 mm, with 1-mm interslice gap.
Statistics
Data were summarized as mean±SD or number of subjects (percentage), as appropriate. Comparisons across the groups were examined using the χ 2 test for categorical variables and Student t test for continuous variables. Participants were categorized into 4 groups according to their 10-year predicted ASCVD risk: <5%, 5% to <7.5%, 7.5% to <10%, and ≥10%. 13 The PCR was also assessed as continuous variable. The relationships between PCR category and SBI, ds-SBI, or hs-SBI were evaluated using a χ 2 linear-by-linear association test in univariate analysis. Multivariable logistic regression analyses were performed to determine whether the PCR model was an independent predictor of SBI, multiple SBIs, ds-SBI, or hs-SBI after adjusting for potential confounders. The lowest risk level of PCR (<5%) was the referent group for purposes of comparison. In addition to the baseline variables having P<0.10 for the presence of SBI/ds-SBI/hs-SBI in univariate analyses (Table 1) , antiplatelet use and lipid modifier use were selected for entry into the multivariable models. Results are given as odds ratios and 95% confidence intervals. A linear trend of adjusted odds ratios across a severity of PCR category was examined using a likelihood ratio test. Model fit was tested using modifications of methods by Lemeshow and Hosmer. 16 Above analyses were conducted using IBM SPSS Version 22.0 (IBM SPSS Inc, Chicago, IL). Accuracies of the PCR model was assessed by calculating c-statistics (areas under the receiver operating characteristic curves) and equations by each race were compared using MedCalc software version 5.0 (Mariakerke, Belgium). A P value of <0.05 was considered statistically significant.
Results
Total Subjects
A total of 1603 subjects (mean age, 56.6±8.3 years; men, 52.3%) were included in this study from 1736 consecutive participants after excluding 133 subjects with missing values for PCR component: 132 with missing smoking and 1 with serum lipid value. Of the 1603 study populations, 175 subjects (10.9%) harbored SBIs (1 SBI in 123, 2 SBIs in 39, and ≥3 SBIs in 13 subjects). Twenty-five percent received antihypertensive medication, 7.8% lipid modifier, and 9.5% antiplatelet use at baseline visits. Demographics and clinical features of subjects with and without SBI are provided in Table 1 . Compared with subjects without SBI, those with SBI were older, had higher levels of systolic blood pressure, waist circumference, glucose, and HbA1c as well as higher frequencies of treatment for high blood pressure and diabetes mellitus, whereas total cholesterol and low-density lipoprotein cholesterol levels were more likely to be lower.
PCR Model and the Presence of SBI/ds-SBI/hs-SBI
The PCR scores between the SBI(+) subjects and SBI(−) subjects were significantly different (all P<0.001 for white and black equations; Table 1 ). Among the 175 SBI(+) subjects, 152 (9.5%) had ds-SBI and 32 (2.0%) hs-SBI. The Figure shows a dose-response relationship between the 4 PCR score category by white (<5%, 5% to <7.5%, 7.5% to <10%, and ≥10%) and SBI severity (1, 2, or ≥3) or prevalence of SBI, ds-SBI, and hs-SBI. Subjects with higher PCR category were more likely to have a higher numbers of SBI (Figure [A] ; P<0.001) and have greater incidence of SBI, ds-SBI, or hs-SBI (Figure [B] ; P<0.001), which was a similar pattern to findings seen in black model (see Figure I in the online-only Data Supplement).
Findings of univariate analyses to test the association between PCR model and presence of SBI/ds-SBI/hs-SBI are provided in Table II Multivariable analyses for the presence of SBI and multiple SBIs by white is shown in Table 2 (see Table III in the online-only Data Supplement for black). Compared with the lowest PCR category (<5%), dose-response relationships were observed between increasing PCR category (5% to <7.5%, 7.5% to <10%, and ≥10%) and presence of SBI, respectively ( Table 3 provides multivariable analyses for the presence of ds-SBI and hs-SBI by white (see Table IV 
Comparison of Model Discrimination by Race
C-statistics of the PCR model with the presence of SBI, multiple SBIs, ds-SBI, and hs-SBI are given in Tables 2 and 3 for white  and in Tables III and IV in Values provided are number (%) or mean±SD, as appropriate, otherwise stated. BP indicates blood pressure; HbA1c, hemoglobin A1c; HDL-C, highdensity lipoprotein cholesterol; hs-CRP, high sensitivity C-reactive protein; LDL-C, low-density lipoprotein cholesterol; PCR, pooled cohort risk; and SBI, silent brain infarction.
*Of them, 152 (9.5%) had deep subcortical SBI and 32 (2.0%) hemispheric SBI. (Tables 2 and 3) . Overall, the PCR seemed to have a higher sensitivity for multiple SBIs and hs-SBI than for SBI or ds-SBI for white or black. 
Discussion
In this analysis of neurologically healthy subjects aged from 40 to 79 years, higher PCR score was significantly associated with a greater prevalence of SBI. PCR as a continuous variable showed significantly increased risk of presence of SBI (1.06, 1.04-1.09), which is a similar pattern to findings from the Framingham Offspring Study (1.27, 1.10-1.46). 9 The risk of SBI increased monotonically with a higher PCR category, and it was significantly increased near 2.5-fold (2-fold for black) higher risk of SBI for the third category (7.5% to <10%) and about 4-fold (4.5-fold for black) for the highest one (≥10%). The risk of multiple SBIs was robustly increased >8-fold higher for the highest categories in white and black. The risk of ds-SBI and hs-SBI also increased substantially with a higher PCR category, and it was significantly increased ≈2.5-and 6-fold higher risk of ds-SBI and hs-SBI, respectively, for the third category and ≈4-and 6-fold risk of ds-SBI and hs-SBI, respectively, for the highest one (similar dose-response pattern to findings from black). When compared between 2 race applications, c-statistics by the receiver operating characteristic curve were fairly compatible with white model and black model for the presence of SBI including multiple SBIs, ds-SBI, and hs-SBI. However, our findings need to be strictly proven through prospective study design.
In this study, the 10-year PCR model did not show high discriminative capacity for the presence of SBI (including ds-SBI) given relatively low c-statistics (<0.70 for either race model), thereby diminishing its potential value. 17 This may not be too surprising because the PCR model was not primarily designed to reflect an index measure of contemporary ischemic burden, but rather to help guide the decision to initiate statin therapy for primary prevention in adults without clinical ASCVD or diabetes mellitus, and with low-density lipoprotein cholesterol levels between 70 and 189 mg/dL. 18 Another explanation for PCR's modest discriminative capacity in this study is that all the participants were Asians. Indeed, the PCR model may have overestimated SBI risk for East Asian ancestry such as Koreans. 12 However, discrimination of the PCR for the presence of multiple SBIs and hs-PBI (by SBI location) was better (all >0.70 for white and black) than the ds-SBI suggesting modest value. 17 Likewise, the PCR was more sensitive in identifying multiple SBIs and hs-SBI than SBI or ds-SBI in both race models. Multiple SBIs correlate advanced vascular disease pattern (versus single SBI). 19 ds-SBI patterns are predominantly lacunes and are mainly associated with small-vessel disease pathology, 8 while hs-SBI (territorial and pial artery mediated) is more prevalent in extracranial large artery disease. 20 These findings conform with recent studies indicating that the PCR was designed to predict hard ASCVD risk, 12 in which large artery atherosclerotic stroke should be considered as high-risk disease of further coronary events. 21 Because the prevalence of hs-SBI (versus ds-SBI) was low (2.0% versus 9.5%), our findings certainly need to be validated with imaging method through larger scale prospective design in future studies. Furthermore, Framingham cardiovascular stroke risk score was significantly linked to cognitive decline, 10 which was related to hs-SBI more than ds-SBI in a longitudinal autopsy study, 5 thus assessing the role of the PCR as a potential predictive tool for assessing risk of dementia and targeting of vascular risk factors is also warranted.
This study has limitations. We explored the relationship between PCR model and SBI including multiple SBIs, ds-SBI, and hs-SBI with a cross-sectional design in a retrospective manner, thus our results cannot confirm a predictive relationship between them. Although SBI and white matter hyperintensities are frequently observed and are the main MRI-defined small-vessel disease, 2,3 we could not adjust for white matter hyperintensities. Thus, our results simply suggest that the PCR could be an indicator of having multiple SBIs or hs-SBI, not mean to provide as a therapeutic/preventive direction for dementia or stroke prevention. Vascular status through angiographic imaging was not available in this database, otherwise could have yielded more concrete results about hs-SBI. Study subjects were neurologically healthy people but information on history of cardiac disease including coronary heart disease, heart failure, or atrial fibrillation was not obtained thereby there being a possibility of unmeasured confounding. Finally, we cannot exclude the possibility of selection bias because of hospital-based setting and age restriction between 40 and 79 years, but our participants were recruited as a large sample size from general populations who visited for routine health check-ups. Furthermore, the prevalence of SBI in our study was 10.9%, a finding that is in accord with that (10.7%) seen in the Framingham Offspring Study. 9 In conclusion, discrimination of the PCR was fairly compatible with white and black for the presence of SBI, including multiple SBIs, ds-SBI, and hs-SBI among stroke free healthy Korean (or Asian) populations. The new PCR model modestly discriminates presence of SBI, but nonetheless might serve as a simple clinical tool for identifying high-risk subjects predisposed to having SBI, particularly multiple SBIs and hs-SBI.
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